by Team Small News | Dec 6, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has partnered with Stempeutics, a stem cell therapy company, to launch a stem cell-based treatment for knee osteoarthritis in India. This innovative therapy aims to provide relief to patients suffering from knee osteoarthritis,... by Team Small News | Dec 1, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has launched a dedicated lung health diagnostics centre in Delhi, India. This initiative is part of the company’s efforts to reimagine Indian healthcare and provide comprehensive care to patients with respiratory... by Team Small News | Nov 29, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has launched India’s first fully integrated Breathefree Lung Wellness Center in Delhi. The center, located in Lajpat Nagar, offers a comprehensive range of services, including over 60 diagnostic tests, pulmonary... by Team Small News | Nov 12, 2025 | Cipla, Natco, Pharma
Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts... by Team Small News | Nov 8, 2025 | Cipla, Pharma
Eli Lilly’s diabetes medication, Mounjaro, has achieved unprecedented success in India’s pharmaceutical market, crossing ₹1 billion in monthly sales. This remarkable feat is a result of the company’s strategic partnership with Cipla, a leading Indian... by Team Small News | Nov 4, 2025 | Cipla, Pharma
Cipla Limited, a leading pharmaceutical company, has announced its plans to acquire a 100% stake in Inzpera Healthsciences Private Limited, a healthcare startup, for a consideration of ₹110.65 crore. This acquisition is expected to strengthen Cipla’s presence in...